Covance

@Covance

Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world's most comprehensive .

Worldwide
Vrijeme pridruživanja: kolovoz 2011.

Tweetovi

Blokirali ste korisnika/cu @Covance

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Covance

  1. Prikvačeni tweet
    5. stu 2019.

    Discover where you are on your path to clinical transformation and how Covance Clinical can help.

    Poništi
  2. prije 7 sati

    We're proud to have participated and to help support the next generation of scientists!

    Poništi
  3. proslijedio/la je Tweet

    Join the 2020 Global Internship Program this year! Work assignments revolve around STEM+ and healthcare fields. Interns will have the chance to see firsthand how Covance is dedicated to its community through philanthropic projects, as well!

    Poništi
  4. prije 8 sati

    As clinical studies get more complex, trial sponsors are seeking more efficient ways to leverage data to better execute studies. Learn what data is essential for better decision making and trial acceleration.

    Poništi
  5. prije 14 sati

    Rare Disease Day is February 29th. Rare is many. Rare is strong. Rare is proud. Join us in sharing your support. ,

    Poništi
  6. prije 15 sati

    Find out how to implement a systematic forced degradation strategy, resulting in defined degradation conditions and time points in this upcoming webinar.

    Poništi
  7. prije 15 sati

    Join us for a one-day event exploring the challenges and issues in a changing chemicals landscape.

    Poništi
  8. prije 20 sati

    Join Louise Kearney and Melissa Harris to learn how Covance is leveraging our proprietary tools and real world data sets to design and conduct studies focused on the needs of patients and their families.

    Poništi
  9. 5. velj

    Save the date for our webinar: Applying Data Analytics and a Decentralized Trial Platform for More Efficient Patient-Centric Trials. Tuesday, February 25 @ 11 a.m. – 12 p.m. CST |Register today:

    Poništi
  10. 5. velj

    How do cell and gene therapies fit in the space? Register to learn more during the Coffee Chat with Paul Byrne - Principal Scientist, Covance.

    Poništi
  11. 3. velj

    Outsourcing in the Cell & Gene Therapy Space - Steven Anderson PhD, CSO Covance, explains how specialized and coordinated capabilities aim to accelerate and reduce risk for sponsors.

    Poništi
  12. 3. velj

    Join Louise Kearney and Melissa Harris to learn how Covance is leveraging our proprietary tools and real world data sets to design and conduct studies focused on the needs of patients and their families.

    Poništi
  13. proslijedio/la je Tweet
    2. velj

    In this exclusive interview, Robert Nelson of (Geneva, Switzerland) discusses biomarkers in drug development, describing the strategies and techniques Covance utilize to effectively develop and validate biomarker assays -

    Poništi
  14. 3. velj

    Need better data management in the lab? Find out how you can improve your data readiness and bridge the gap between the lab and clinical CROs for more efficient, optimized studies. Learn more:

    Poništi
  15. 3. velj

    Only 10-20% of meet enrollment timelines while roughly 80% don’t finish on time. We leverage unique-to-the-industry data sets and tech applications that provide actionable insights and powerful results. Watch the video

    Poništi
  16. 2. velj

    How do you define success of your risk-based quality approach? Do you have one set of metrics in place for your organization – and can they be improved? Join our educational webinar on Feb. 4 as we discuss these questions and more.

    Poništi
  17. 2. velj

    How do you define success of your risk-based quality approach? Do you have one set of metrics in place for your organization – and can they be improved? Join our educational webinar on Feb. 4 as we discuss these questions and more.

    Poništi
  18. 31. sij

    Putting Patient Convenience First: Creating Next-Generation Product Access Support Programs that Drive Engagement and Utilization

    Poništi
  19. 31. sij

    Covance has unique-to-the-industry proprietary data sets working together to provide actionable insights to accelerate . Watch the video >

    Poništi
  20. proslijedio/la je Tweet
    29. sij

    Two announcements this week about large players investing in cell & gene therapy. This time, announces a new suite of offerings to help sponsors reduce development time and risk. More>>

    Poništi
  21. proslijedio/la je Tweet
    30. sij

    Robert Nelson () Geneva, Switzerland) discusses the importance of biomarkers in drug development, describing key aspects in the current guidance and key considerations to make in the development and validation process. Watch the full interview now:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·